The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 05, 2024

Filed:

Jul. 12, 2018
Applicant:

Bgi Shenzhen, Shenzhen, CN;

Inventors:

Fei Wang, Shenzhen, CN;

Chengchi Chao, Shenzhen, CN;

Bo Li, Shenzhen, CN;

Yong Hou, Shenzhen, CN;

Yuelu Yin, Shenzhen, CN;

Shilei Wang, Shenzhen, CN;

Kun Duan, Shenzhen, CN;

Assignee:

BGI SHENZHEN, Shenzhen, CN;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/725 (2006.01); C12N 5/0783 (2010.01); C12N 5/10 (2006.01); C12N 15/867 (2006.01);
U.S. Cl.
CPC ...
C07K 14/7051 (2013.01); C12N 5/0636 (2013.01); C12N 5/10 (2013.01); C12N 15/867 (2013.01); C07K 2317/565 (2013.01);
Abstract

Provided is a MART-1 (27-35) epitope-specific T cell receptor, comprising an α chain and a β chain. The α chain comprises three complementary determining regions, respective sequences thereof being positions 61-66, positions 84-89, and positions 124-136 of SEQ ID No. 3. The β chain comprises three complementary determining regions, respective amino acid sequences thereof being positions 46-50, positions 68-73, and positions 112-125 of SEQ ID No. 4. A T cell expressing the TCR can effectively recognize a MART-1 (27-35) epitope polypeptide supported on a T2 cell and secrete IFN-γ, thereby demonstrating the functionality of the receptor. Use of the TCR with a relevant drug target allows for effective drug development.


Find Patent Forward Citations

Loading…